Doxycycline Hyclate
NDC Package 24658-311-60

11-digit billing NDC: 24658031160

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Doxycycline Hyclate is to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. Marketed by Puracap Laboratories Llc Dba Blu Pharmaceuticals, this product is identified by NDC 24658-311 and is authorized under FDA application ANDA062269.

Identification & Billing

NDC Package Code
24658-311-60
Package Description
60 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
24658031160
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Doxycycline Hyclate
Dosage Form
-
Usage Information
To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Regulatory & Marketing

Labeler Name
Puracap Laboratories Llc Dba Blu Pharmaceuticals
FDA Application #
ANDA062269
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-19-2021
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24658-311-60 identifies a specific commercial package of 60 tablet in 1 bottle of Doxycycline Hyclate, labeled by Puracap Laboratories Llc Dba Blu Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Puracap Laboratories Llc Dba Blu Pharmaceuticals on November 19, 2021. The current certification is valid through December 31, 2025.

How is this Puracap Laboratories Llc Dba Blu Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24658031160. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
24658-311-60
11-Digit CMS (5-4-2)
24658-0311-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.